Literature DB >> 27577866

T-cell exhaustion: understanding the interface of chronic viral and autoinflammatory diseases.

Eoin F McKinney1, Kenneth Gc Smith1.   

Abstract

During acute viral infection CD8 T cells rapidly expand before contracting down to a persistent memory population that confers long-lasting immunity. However when the antigen persists, such as during chronic viral infection, a dysfunctional process termed 'exhaustion' limits the antiviral response, facilitating ongoing viraemia and poor clinical outcome. CD8 T-cell exhaustion was originally identified in lymphocytic choriomeningitis virus infection of mice; however, new evidence has shown that exhaustion is associated with the control of a wide range of human chronic inflammatory states, including chronic viral infection, autoimmunity and cancer. Consequently, an understanding of the mechanisms controlling exhaustion during chronic infection may also indicate new strategies for controlling other chronic inflammatory diseases. In particular, the success of immune checkpoint blockade as a form of cancer immunotherapy has prompted renewed efforts to understand how T-cell immunity to chronic antigenic stimulation might similarly be measured or modulated in autoimmune diseases. Here we summarise the mechanisms controlling T-cell exhaustion and how they relate to the control of autoimmune responses, providing a future perspective on measuring or manipulating exhaustion to personalise therapy.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27577866     DOI: 10.1038/icb.2016.81

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  123 in total

1.  Antigen-specific CD4 T-cell help rescues exhausted CD8 T cells during chronic viral infection.

Authors:  Rachael D Aubert; Alice O Kamphorst; Surojit Sarkar; Vaiva Vezys; Sang-Jun Ha; Daniel L Barber; Lilin Ye; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

2.  Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity.

Authors:  Philipp A Lang; Karl S Lang; Haifeng C Xu; Melanie Grusdat; Ian A Parish; Mike Recher; Alisha R Elford; Salim Dhanji; Namir Shaabani; Charles W Tran; Dilan Dissanayake; Ramtin Rahbar; Magar Ghazarian; Anne Brüstle; Jason Fine; Peter Chen; Casey T Weaver; Christoph Klose; Andreas Diefenbach; Dieter Häussinger; James R Carlyle; Susan M Kaech; Tak W Mak; Pamela S Ohashi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

3.  Role of antigen persistence and dose for CD4+ T-cell exhaustion and recovery.

Authors:  Shaobo Han; Ayuna Asoyan; Hannah Rabenstein; Naoko Nakano; Reinhard Obst
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

4.  Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.

Authors:  Laurent Monney; Catherine A Sabatos; Jason L Gaglia; Akemi Ryu; Hanspeter Waldner; Tatyana Chernova; Stephen Manning; Edward A Greenfield; Anthony J Coyle; Raymond A Sobel; Gordon J Freeman; Vijay K Kuchroo
Journal:  Nature       Date:  2002-01-31       Impact factor: 49.962

5.  Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells.

Authors:  Nir Yogev; Friederike Frommer; Dominika Lukas; Kordula Kautz-Neu; Khalad Karram; Daniele Ielo; Esther von Stebut; Hans-Christian Probst; Maries van den Broek; Dieter Riethmacher; Tal Birnberg; Thomas Blank; Boris Reizis; Thomas Korn; Heinz Wiendl; Steffen Jung; Marco Prinz; Florian C Kurschus; Ari Waisman
Journal:  Immunity       Date:  2012-08-16       Impact factor: 31.745

6.  Blockade of chronic type I interferon signaling to control persistent LCMV infection.

Authors:  Elizabeth B Wilson; Douglas H Yamada; Heidi Elsaesser; Jonathan Herskovitz; Jane Deng; Genhong Cheng; Bruce J Aronow; Christopher L Karp; David G Brooks
Journal:  Science       Date:  2013-04-12       Impact factor: 47.728

7.  Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope.

Authors:  Ludmila Prokunina; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jonathan Prince; Lars Alfredsson; Lars Klareskog; Marta Alarcón-Riquelme
Journal:  Arthritis Rheum       Date:  2004-06

8.  Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease.

Authors:  Y Ban; T F Davies; D A Greenberg; A Kissin; B Marder; B Murphy; E S Concepcion; R B Villanueva; G Barbesino; V Ling; Y Tomer
Journal:  Genes Immun       Date:  2003-12       Impact factor: 2.676

9.  Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway.

Authors:  Brian T Fife; Indira Guleria; Melanie Gubbels Bupp; Todd N Eagar; Qizhi Tang; Helene Bour-Jordan; Hideo Yagita; Miyuki Azuma; Mohamed H Sayegh; Jeffrey A Bluestone
Journal:  J Exp Med       Date:  2006-11-20       Impact factor: 14.307

10.  Lymphocyte Activation Gene-3 (LAG-3) negatively regulates environmentally-induced autoimmunity.

Authors:  Vibha Jha; Creg J Workman; Tracy L McGaha; Liping Li; Jaya Vas; Dario A A Vignali; Marc Monestier
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

View more
  9 in total

1.  Novel aspects of autoimmunity.

Authors:  Kenneth Gc Smith; Arthur Kaser
Journal:  Immunol Cell Biol       Date:  2016-11       Impact factor: 5.126

2.  [Oxidized low-density lipoprotein modulates differentiation of murine memory CD8+ T cell subpopulations].

Authors:  Hua Zheng; Ze-Hang Lin; Yan-Mei Zhang; Chen-Fei Zhou; Xuan Liu; Sha Wu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-08-20

Review 3.  Under-Evaluated or Unassessed Pathogenic Pathways in Autoimmune Hepatitis and Implications for Future Management.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2018-04-18       Impact factor: 3.199

4.  Lymphocytic Thyroiditis Transcriptomic Profiles Support the Role of Checkpoint Pathways and B Cells in Pathogenesis.

Authors:  Daniel Álvarez-Sierra; Ana Marín-Sánchez; Aroa Gómez-Brey; Irene Bello; Enric Caubet; Pablo Moreno-Llorente; Anna Petit; Carles Zafón; Carmela Iglesias; Óscar González; Ricardo Pujol-Borrell
Journal:  Thyroid       Date:  2022-05-25       Impact factor: 6.506

Review 5.  Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy.

Authors:  Naomi I Maria; Anne Davidson
Journal:  Nat Rev Rheumatol       Date:  2020-03-19       Impact factor: 20.543

Review 6.  Metabolic adaptations of tissue-resident immune cells.

Authors:  George Caputa; Angela Castoldi; Edward J Pearce
Journal:  Nat Immunol       Date:  2019-06-18       Impact factor: 25.606

7.  Silymarin suppresses basal and stimulus-induced activation, exhaustion, differentiation, and inflammatory markers in primary human immune cells.

Authors:  Erica S Lovelace; Nicholas J Maurice; Hannah W Miller; Chloe K Slichter; Robert Harrington; Amalia Magaret; Martin Prlic; Stephen De Rosa; Stephen J Polyak
Journal:  PLoS One       Date:  2017-02-03       Impact factor: 3.240

8.  PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited.

Authors:  Samuel Knauss; Corinna Preusse; Yves Allenbach; Sarah Leonard-Louis; Mehdi Touat; Norina Fischer; Helena Radbruch; Ronja Mothes; Vitali Matyash; Wolfgang Böhmerle; Matthias Endres; Hans-Hilmar Goebel; Olivier Benveniste; Werner Stenzel
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-04-10

Review 9.  T Follicular Helper Cells and B Cell Dysfunction in Aging and HIV-1 Infection.

Authors:  Suresh Pallikkuth; Lesley de Armas; Stefano Rinaldi; Savita Pahwa
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.